* The Board of Directors of Diligent Media Corporation Limited, at its meeting held on November 14, 2025, approved the unaudited financial results for the second quarter and half year ended September 30, 2025, for the Financial Year 2025-26. * The results were reviewed by M/s MGB & Co. LLP, Chartered Accountants, who issued a Limited Review Report with a modified opinion. * Financial Performance (Unaudited, ₹ in lakhs): * For the quarter ended September 30, 2025: * Revenue from operations: ₹268.96 * Total Income: ₹274.62 * Profit/(Loss) after tax: (₹66.79) * Basic and Diluted Earnings Per Share (EPS): (₹0.06) * For the half year ended September 30, 2025: * Revenue from operations: ₹347.63 * Total Income: ₹355.42 * Profit/(Loss) after tax: (₹55.39) * Basic and Diluted Earnings Per Share (EPS): (₹0.05) * Arbitration and Corporate Action regarding ICDs and NCRPS: * The company had granted unsecured Inter Corporate Deposits (ICDs) to Veena Investments Private Limited (VIPL), with an outstanding balance of ₹17,340.27 lakhs (including accrued interest) as of September 30, 2025. * VIPL simultaneously holds 6% Non-cumulative Non-convertible Redeemable Preference Shares (NCRPS) of the Company aggregating to ₹43,626.56 lakhs, redeemable on November 1, 2036. * An Arbitration Award dated August 20, 2025, directed the company to redeem/cancel the said NCRPS at a value of ₹17,340.27 lakhs, with VIPL setting off the entire ICDs outstanding amount against this NCRPS value. * Pursuant to this, the Board approved a Scheme of Reduction and cancellation of NCRPS Capital for ₹17,340.27 lakhs on September 18, 2025, to be adjusted against the outstanding ICDs. The remaining paid-up value of NCRPS Capital amounting to ₹26,286.29 lakhs will also be reduced. * The Scheme was filed with BSE Limited on October 7, 2025, and with the National Stock Exchange of India Limited on October 8, 2025. * Auditor's Qualified Conclusion and Going Concern: * The auditors issued a qualified conclusion because the company did not assess the recoverability of the ICDs in accordance with Ind AS 109, stating that the consequential impact on the financial statements is presently unascertainable. * The auditors also highlighted a
